SPRY — ARS Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for ARS Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	9.98	387	254	274	228
Prepaid Expenses
Total Current Assets	10.5	391	261	278	232
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.57	3.8	6.95	0.774	0.824
Long Term Investments
Other Long Term Assets
Total Assets	15.6	395	333	281	233
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17.9	9.6	14.9	5.44	2.39
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.3	11.9	19.7	8.55	2.43
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-5.6	383	314	273	231
Total Liabilities & Shareholders' Equity	15.6	395	333	281	233
Total Common Shares Outstanding